Judith Versluis

I started my PhD in March 2019 in the Blank group.

My project focuses on identification of alternative neoadjuvant combination schemes for biomarker-unfavorable stage III melanoma patients and on patterns of response and recurrence in both stage III and stage IV melanoma patients.